Researchers at Karolinska Institutet have now shown that material from nasal lavage provides a basis for assessing COPD. The ...
5d
Health on MSNWhat's the Difference Between Asthma and Chronic Obstructive Pulmonary Disease (COPD)?Medically reviewed by Sanja Jelic, MD Asthma and chronic obstructive pulmonary disease (COPD) are chronic respiratory (lung) ...
The systemic immune response index outperformed other inflammatory markers in predicting chronic obstructive pulmonary ...
Elevated IL-26 levels in the nose of smokers with and without COPD may provide a simple method for early detection and ...
and IL-26 has previously been linked to various inflammatory diseases, including COPD. In COPD, the levels of IL-26 in the lower respiratory tract have been shown to be elevated. In the current ...
Dupixent (dupilumab) is available in Japan in a 300 mg dose as a pre-filled syringe or pre-filled pen and is now available ...
Press Release: Dupixent approved as the first-ever biologic medicine in Japan for patients with COPD
Dupixent approved as the first-ever biologic medicine in Japan for patients with COPDFollowing recent approvals in the EU, China, and the US, ...
Chronic obstructive pulmonary disease (COPD) is a major cause of death among patients with renal cell carcinoma (RCC) in the United States, investigators reported at ASCO’s 2025 Genitourinary Cancers ...
Following recent approvals in the EU, China and the U.S., this approval was based on pivotal Phase 3 results in adults with elevated eosinophils ...
Sanofi & Regeneron’s Dupixent receives Japanese marketing approval to treat patients with COPD: Paris Saturday, March 29, 2025, 09:00 Hrs [IST] The Ministry of Health, Labour an ...
Press Release: Dupixent approved as the first-ever biologic medicine in Japan for patients with COPD
Following recent approvals in the EU, China, and the US, this approval was based on pivotal phase 3 results in adults with elevated eosinophils Approval marks the first new treatment approach for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results